On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity—An observational study
Abstract Background Occasionally, patients show dramatic recovery from disorders of consciousness (DOC) under intrathecal baclofen (ITB), an established treatment option for severe supraspinal spasticity. Anecdotal explanations for ITB‐related recovery of cognition include modulation of afferent imp...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-05-01
|
Series: | Brain and Behavior |
Subjects: | |
Online Access: | https://doi.org/10.1002/brb3.2566 |
_version_ | 1797737268539031552 |
---|---|
author | Lucas‐Michael Halbmayer Markus Kofler Gabriel Hitzenberger Heinrich Matzak Elena Fava Eleonora Genelin Mario Werkmann Leopold Saltuari Viviana Versace Judith Dobesberger Elke Pucks‐Faes |
author_facet | Lucas‐Michael Halbmayer Markus Kofler Gabriel Hitzenberger Heinrich Matzak Elena Fava Eleonora Genelin Mario Werkmann Leopold Saltuari Viviana Versace Judith Dobesberger Elke Pucks‐Faes |
author_sort | Lucas‐Michael Halbmayer |
collection | DOAJ |
description | Abstract Background Occasionally, patients show dramatic recovery from disorders of consciousness (DOC) under intrathecal baclofen (ITB), an established treatment option for severe supraspinal spasticity. Anecdotal explanations for ITB‐related recovery of cognition include modulation of afferent impulses at the spinal level, thereby reducing spasticity‐related proprioceptive information overload within cortico–thalamo–cortical connections. Objective In this retrospective patient chart analysis, we assessed whether a reduction in spasticity would be associated with an increase in Coma Recovery Scale revised (CRS‐R) scores in a larger sample of patients than previously published. Methods From a hospital‐based ITB treatment register, we extracted data from 26 patients with DOC and severe supraspinal spasticity who improved by >2 points on the Coma Recovery Scale revised (CRS‐R) within 6 months after ITB treatment initiation. We assessed Modified Ashworth scale (MAS) scores and CRS‐R scores on admission (PRE) and 3 and 6 months after initiation of ITB treatment (3M, 6M). We performed correlation analysis of the scores and their respective changes (PRE to 3M, 3M to 6M). We also correlated the time from acute event until ITB initiation to CRS‐R scores at 3M and 6M. Results ITB led to significant improvement in spasticity based on MAS scores, which did not correlate to the improvements seen in CRS‐R total and subscale scores. Daily ITB dose did neither correlate to MAS scores nor to CRS‐total scores in the whole patient group, but after 3 months, ITB dose correlated to some CRS‐R subscale scores in some patient subgroups. Time until ITB treatment did not correlate to CRS‐R scores later on. Conclusions Our data confirm that ITB may exert beneficial effects in selected DOC patients with respect to improved cognitive functions, which, however, do not correlate to its antispastic effect. The lack of correlation between time to ITB and CRS‐R outcome, but significant CRS‐R improvements following pump implantation, renders spontaneous remissions unlikely and leaves room for alternative pharmacological mechanisms. |
first_indexed | 2024-03-12T13:26:12Z |
format | Article |
id | doaj.art-294899c023134f75b3abe2fbee16af8f |
institution | Directory Open Access Journal |
issn | 2162-3279 |
language | English |
last_indexed | 2024-03-12T13:26:12Z |
publishDate | 2022-05-01 |
publisher | Wiley |
record_format | Article |
series | Brain and Behavior |
spelling | doaj.art-294899c023134f75b3abe2fbee16af8f2023-08-25T04:42:55ZengWileyBrain and Behavior2162-32792022-05-01125n/an/a10.1002/brb3.2566On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity—An observational studyLucas‐Michael Halbmayer0Markus Kofler1Gabriel Hitzenberger2Heinrich Matzak3Elena Fava4Eleonora Genelin5Mario Werkmann6Leopold Saltuari7Viviana Versace8Judith Dobesberger9Elke Pucks‐Faes10Department of Neurology Hochzirl Hospital Zirl AustriaDepartment of Neurology Hochzirl Hospital Zirl AustriaDepartment of Neurology Hochzirl Hospital Zirl AustriaDepartment of Neurology Hochzirl Hospital Zirl AustriaDepartment of Neurology Hochzirl Hospital Zirl AustriaDepartment of Neurology Hochzirl Hospital Zirl AustriaDepartment of Neurology Hochzirl Hospital Zirl AustriaDepartment of Neurorehabilitation Hospital of Vipiteno (SABES‐ASDAA) Vipiteno ItalyDepartment of Neurorehabilitation Hospital of Vipiteno (SABES‐ASDAA) Vipiteno ItalyRehabilitation Center Großgmain, Pensionsversicherungsanstalt Teaching Hospital of Paracelsus Medical University Salzburg AustriaDepartment of Neurology Hochzirl Hospital Zirl AustriaAbstract Background Occasionally, patients show dramatic recovery from disorders of consciousness (DOC) under intrathecal baclofen (ITB), an established treatment option for severe supraspinal spasticity. Anecdotal explanations for ITB‐related recovery of cognition include modulation of afferent impulses at the spinal level, thereby reducing spasticity‐related proprioceptive information overload within cortico–thalamo–cortical connections. Objective In this retrospective patient chart analysis, we assessed whether a reduction in spasticity would be associated with an increase in Coma Recovery Scale revised (CRS‐R) scores in a larger sample of patients than previously published. Methods From a hospital‐based ITB treatment register, we extracted data from 26 patients with DOC and severe supraspinal spasticity who improved by >2 points on the Coma Recovery Scale revised (CRS‐R) within 6 months after ITB treatment initiation. We assessed Modified Ashworth scale (MAS) scores and CRS‐R scores on admission (PRE) and 3 and 6 months after initiation of ITB treatment (3M, 6M). We performed correlation analysis of the scores and their respective changes (PRE to 3M, 3M to 6M). We also correlated the time from acute event until ITB initiation to CRS‐R scores at 3M and 6M. Results ITB led to significant improvement in spasticity based on MAS scores, which did not correlate to the improvements seen in CRS‐R total and subscale scores. Daily ITB dose did neither correlate to MAS scores nor to CRS‐total scores in the whole patient group, but after 3 months, ITB dose correlated to some CRS‐R subscale scores in some patient subgroups. Time until ITB treatment did not correlate to CRS‐R scores later on. Conclusions Our data confirm that ITB may exert beneficial effects in selected DOC patients with respect to improved cognitive functions, which, however, do not correlate to its antispastic effect. The lack of correlation between time to ITB and CRS‐R outcome, but significant CRS‐R improvements following pump implantation, renders spontaneous remissions unlikely and leaves room for alternative pharmacological mechanisms.https://doi.org/10.1002/brb3.2566brainstemComa Recovery Scale‐Revisedconsciousness recoverydisorders of consciousnessintrathecal baclofenpedunculopontine nucleus |
spellingShingle | Lucas‐Michael Halbmayer Markus Kofler Gabriel Hitzenberger Heinrich Matzak Elena Fava Eleonora Genelin Mario Werkmann Leopold Saltuari Viviana Versace Judith Dobesberger Elke Pucks‐Faes On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity—An observational study Brain and Behavior brainstem Coma Recovery Scale‐Revised consciousness recovery disorders of consciousness intrathecal baclofen pedunculopontine nucleus |
title | On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity—An observational study |
title_full | On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity—An observational study |
title_fullStr | On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity—An observational study |
title_full_unstemmed | On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity—An observational study |
title_short | On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity—An observational study |
title_sort | on the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity an observational study |
topic | brainstem Coma Recovery Scale‐Revised consciousness recovery disorders of consciousness intrathecal baclofen pedunculopontine nucleus |
url | https://doi.org/10.1002/brb3.2566 |
work_keys_str_mv | AT lucasmichaelhalbmayer ontherecoveryofdisordersofconsciousnessunderintrathecalbaclofenadministrationforseverespasticityanobservationalstudy AT markuskofler ontherecoveryofdisordersofconsciousnessunderintrathecalbaclofenadministrationforseverespasticityanobservationalstudy AT gabrielhitzenberger ontherecoveryofdisordersofconsciousnessunderintrathecalbaclofenadministrationforseverespasticityanobservationalstudy AT heinrichmatzak ontherecoveryofdisordersofconsciousnessunderintrathecalbaclofenadministrationforseverespasticityanobservationalstudy AT elenafava ontherecoveryofdisordersofconsciousnessunderintrathecalbaclofenadministrationforseverespasticityanobservationalstudy AT eleonoragenelin ontherecoveryofdisordersofconsciousnessunderintrathecalbaclofenadministrationforseverespasticityanobservationalstudy AT mariowerkmann ontherecoveryofdisordersofconsciousnessunderintrathecalbaclofenadministrationforseverespasticityanobservationalstudy AT leopoldsaltuari ontherecoveryofdisordersofconsciousnessunderintrathecalbaclofenadministrationforseverespasticityanobservationalstudy AT vivianaversace ontherecoveryofdisordersofconsciousnessunderintrathecalbaclofenadministrationforseverespasticityanobservationalstudy AT judithdobesberger ontherecoveryofdisordersofconsciousnessunderintrathecalbaclofenadministrationforseverespasticityanobservationalstudy AT elkepucksfaes ontherecoveryofdisordersofconsciousnessunderintrathecalbaclofenadministrationforseverespasticityanobservationalstudy |